Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC
about
The endocannabinoid system, cannabinoids, and painValidation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid.Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.Effect of hydrolysis on identifying prenatal cannabis exposureDisposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers.Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.Prevalence and correlates of hashish use in a national sample of high school seniors in the United States.Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THCPsychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabisIdentification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administrationAntagonist-elicited cannabis withdrawal in humansOral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administrationOral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome.Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices.Letter to the editor regarding "Simultaneous determination of ∆9-tetrahydrocannabinol and 11-nor-9-carboxy-∆9-tetrahydrocannabinol in oral fluid using isotope dilution liquid chromatography tandem mass spectrometry".Cannabidiol Does Not Convert to Δ9-Tetrahydrocannabinol in an In Vivo Animal Model.Scientific Opinion on the risks for human health related to the presence of tetrahydrocannabinol (THC) in milk and other food of animal originA review of methods for the chemical characterization of cannabis natural products.Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.An overview of quantifying and screening drugs of abuse in biological samples: Past and present
P2860
Q24601890-3BD3644F-A1A8-4B73-84E0-4FF9DF2FA152Q34107928-6283C1C5-5450-4965-A9AE-66BC1F04E023Q35173356-666A8F5D-631D-423C-BC27-ED8DE6FA92FCQ35184670-8C0EA304-068F-43C7-B4BD-C6DF460C841AQ35209227-49935619-2C5C-45E8-974B-2EA36396E07FQ35956980-118E4059-29DA-438B-8541-02C65A559F31Q36087946-B913D4F2-7D53-41C5-84DF-C714A3A63630Q36169683-FB2093B2-BAC2-4AA3-B232-8D6E41077CB3Q36288383-CC0BADB0-D08E-4B94-B4A2-5DF711014AB0Q36471630-AB5BD447-250C-453A-A19C-F66DD8B3C8A2Q37029480-18206A42-28A0-4DF9-A240-3F22445C95C6Q37029517-BA391E9A-863F-45C7-B323-758DCACB176AQ37136230-7D6AA254-9B0D-4F7A-8498-9CF470A425C0Q37331681-B82A26D2-04A9-4CDA-9770-FB2FDD5D8E0EQ37351687-D5328926-C6EA-4473-96AC-AE0FA5F60CD9Q37405838-F4987379-CB54-4884-8A01-A4C803F2D715Q37639351-E6AAB0D7-D748-4F2A-88CD-4F4B48685CF6Q38161854-EAC38CB3-8B2B-489F-86BD-7A30A803DFF6Q46174361-1B2E9AB1-9549-4839-93A8-59AD16064900Q47109003-67B1259A-C519-4B37-9BBD-2C8EDC577F6CQ47157045-E5B5B636-0850-42E4-9CC9-B5D8068A897AQ48229288-5E733D0A-A162-402F-9679-6B7573746882Q50166610-34D7E0E6-B575-4206-9F96-499FE10DA995Q54243217-2D4B6C6E-E208-4DB1-9ADE-EC2C00C04602Q54645752-837B212A-724D-4F41-B479-33A07FE83C35Q57756369-29B10C64-9BFD-4416-A08E-18018EE3157D
P2860
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@ast
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@en
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@nl
type
label
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@ast
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@en
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@nl
prefLabel
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@ast
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@en
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@nl
P2093
P2860
P921
P1433
P1476
Delta9-tetrahydrocannabinol (T ...... continuous high-dose oral THC
@en
P2093
David A Gorelick
David M Schwope
Deanna L Kelly
Erin L Karschner
Eugene W Schwilke
Robert S Goodwin
Ross H Lowe
William D Darwin
P2860
P304
P356
10.1373/CLINCHEM.2008.122119
P407
P577
2009-12-01T00:00:00Z